0000930413-21-000037.txt : 20210113 0000930413-21-000037.hdr.sgml : 20210113 20210113213750 ACCESSION NUMBER: 0000930413-21-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210111 FILED AS OF DATE: 20210113 DATE AS OF CHANGE: 20210113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bench David CENTRAL INDEX KEY: 0001797876 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 21527364 MAIL ADDRESS: STREET 1: ENZO BIOCHEM, INC. STREET 2: 527 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 ownership.xml X0306 4 2021-01-11 0 0000316253 ENZO BIOCHEM INC ENZ 0001797876 Bench David C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022 0 1 0 0 CHIEF FINANCIAL OFFICER Stock Option (to acquire Common Stock) 2.63 2021-01-11 4 A 0 55400 0 A 2022-01-11 2026-01-11 Common Stock 55400 110800 D The Reporting Person was granted 55,400 stock options. The stock options have a three-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date. Does not include 15,000 Performance Stock Units granted to the Reporting Person on February 24, 2020, which will vest, if at all, based on (i) the achievement of certain average revenue growth and average adjusted EBITDA growth goals on February 24, 2023 and (ii) the continued employment of the Reporting Person through February 24, 2023. /s/ David Bench 2021-01-13